Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 530 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
MINI REVIEW
Year : 2012  |  Volume : 16  |  Issue : 8  |  Page : 252-255

Where do conventional OADs stand


1 Department of Endocrinology, Osmania Medical College & Hospital, Hyderabad, India
2 Department of Endocrinology, Care Hospital, Hyderabad, India

Correspondence Address:
Rakesh Kumar Sahay
Department of Endocrinology, Osmania Medical College & Hospital, Hyderabad
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-8210.104053

Rights and Permissions

The last two decades have witnessed unprecedented activity in the field of OADs with many new drugs becoming available. Concerns with OAD include cardiovascular safety, fear about hypoglycemia, weight gain etc. In this article we attempt to review OADs , sulfonylureas in particular, in the light of the newer agents.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1062    
    Printed33    
    Emailed0    
    PDF Downloaded272    
    Comments [Add]    

Recommend this journal